Advertisement
Therapeutics, Targets, and Chemical Biology

A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma

Eli M. Wallace, James P. Rizzi, Guangzhou Han, Paul M. Wehn, Zhaodan Cao, Xinlin Du, Tzuling Cheng, Robert M. Czerwinski, Darryl D. Dixon, Barry S. Goggin, Jonas A. Grina, Megan M. Halfmann, Melissa A. Maddie, Sarah R. Olive, Stephen T. Schlachter, Huiling Tan, Bin Wang, Keshi Wang, Shanhai Xie, Rui Xu, Hanbiao Yang and John A. Josey
DOI: 10.1158/0008-5472.CAN-16-0473 Published September 2016

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: September 2016 to December 2019

AbstractFull-text HTMLPDF
Total246977616073

Cited By

Article Information

Volume 76, Issue 18, pp. 5491-5500

DOI 
https://doi.org/10.1158/0008-5472.CAN-16-0473
PubMed 
27635045
Published By 
American Association for Cancer Research
Print ISSN 
0008-5472
Online ISSN 
1538-7445
History 
  • Received February 22, 2016
  • Revision received June 19, 2016
  • Accepted July 6, 2016
  • Published first September 6, 2016.

Article Versions

Copyright & Usage 
©2016 American Association for Cancer Research.

Author Information

  1. Eli M. Wallace*,
  2. James P. Rizzi,
  3. Guangzhou Han,
  4. Paul M. Wehn,
  5. Zhaodan Cao,
  6. Xinlin Du,
  7. Tzuling Cheng,
  8. Robert M. Czerwinski,
  9. Darryl D. Dixon,
  10. Barry S. Goggin,
  11. Jonas A. Grina,
  12. Megan M. Halfmann,
  13. Melissa A. Maddie,
  14. Sarah R. Olive,
  15. Stephen T. Schlachter,
  16. Huiling Tan,
  17. Bin Wang,
  18. Keshi Wang,
  19. Shanhai Xie,
  20. Rui Xu,
  21. Hanbiao Yang, and
  22. John A. Josey
  1. Peloton Therapeutics, Inc., Dallas, Texas.
  1. ↵*Corresponding Author:
    Eli M. Wallace, Peloton Therapeutics Inc., 2330 Inwood Road, Suite 226, Dallas, TX 75235. Phone: 972-629-4126; Fax: 972-629-4111; E-mail: eli.wallace{at}pelotontx.com

  • Current address for D.D. Dixon: Bristol-Myers Squibb, New Brunswick, New Jersey; current address for M.M. Halfmann: Stowers Institute for Medical Research, Kansas City, Missouri; current address for M.A. Maddie: Renovo Neural, Inc., Cleveland, Ohio; and current address for S.R. Olive: Progen Lab, Dallas, Texas.

View Full Text
Back to top
Cancer Research: 76 (18)
September 2016
Volume 76, Issue 18

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Email Article
Citation Tools
A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma
Eli M. Wallace, James P. Rizzi, Guangzhou Han, Paul M. Wehn, Zhaodan Cao, Xinlin Du, Tzuling Cheng, Robert M. Czerwinski, Darryl D. Dixon, Barry S. Goggin, Jonas A. Grina, Megan M. Halfmann, Melissa A. Maddie, Sarah R. Olive, Stephen T. Schlachter, Huiling Tan, Bin Wang, Keshi Wang, Shanhai Xie, Rui Xu, Hanbiao Yang and John A. Josey
Cancer Res September 15 2016 (76) (18) 5491-5500; DOI: 10.1158/0008-5472.CAN-16-0473
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section

Advertisement